(Q44745485)

5 December 2017

Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac (English)

1 reference

5 December 2017

1 reference

1 reference

David C Brousseau

1

1 reference

5 December 2017

Susan J Duffy

series ordinal

2

1 reference

5 December 2017

Angela C Anderson

series ordinal

3

1 reference

5 December 2017

James G Linakis

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Annals of Emergency Medicine

5 December 2017

1 reference

5 December 2017

43

1 reference

5 December 2017

256-262

1 reference

5 December 2017

2

1 reference

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Migraine in childhood and its prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

An epidemiologic study of headache among children and adolescents of southern Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Headaches in a pediatric emergency department: etiology, imaging, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Acute headache in children and adolescents presenting to the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Tolerability and effectiveness of prochlorperazine for intractable migraine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Treatment of juvenile migraine with subcutaneous sumatriptan.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Diagnosis and treatment of migraine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

The placebo effect in acute headache management: ketorolac, meperidine, and saline in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Emergency department management of pediatric migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Migraine and headache in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Emergency management of migraine: is the headache really over?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Droperidol vs. prochlorperazine for benign headaches in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2803%2900716-9

7 January 2021

10.1016/S0196-0644(03)00716-9

Identifiers

DOI

1 reference

5 December 2017

1 reference